UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus

Granno, S; Nixon-Abell, J; Berwick, DC; Tosh, J; Heaton, G; Almudimeegh, S; Nagda, Z; ... Harvey, K; + view all (2019) Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus. Scientific Reports , 9 (1) , Article 7322. 10.1038/s41598-019-43820-4. Green open access

[thumbnail of Fisher_Downregulated Wnt β-catenin signalling in the Down syndrome hippocampus_VoR.pdf]
Preview
Text
Fisher_Downregulated Wnt β-catenin signalling in the Down syndrome hippocampus_VoR.pdf - Published Version

Download (6MB) | Preview

Abstract

Pathological mechanisms underlying Down syndrome (DS)/Trisomy 21, including dysregulation of essential signalling processes remain poorly understood. Combining bioinformatics with RNA and protein analysis, we identified downregulation of the Wnt/β-catenin pathway in the hippocampus of adult DS individuals with Alzheimer’s disease and the ‘Tc1’ DS mouse model. Providing a potential underlying molecular pathway, we demonstrate that the chromosome 21 kinase DYRK1A regulates Wnt signalling via a novel bimodal mechanism. Under basal conditions, DYRK1A is a negative regulator of Wnt/β-catenin. Following pathway activation, however, DYRK1A exerts the opposite effect, increasing signalling activity. In summary, we identified downregulation of hippocampal Wnt/β-catenin signalling in DS, possibly mediated by a dose dependent effect of the chromosome 21-encoded kinase DYRK1A. Overall, we propose that dosage imbalance of the Hsa21 gene DYRK1A affects downstream Wnt target genes. Therefore, modulation of Wnt signalling may open unexplored avenues for DS and Alzheimer’s disease treatment.

Type: Article
Title: Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1038/s41598-019-43820-4
Publisher version: http://doi.org/10.1038/s41598-019-43820-4
Language: English
Additional information: © The Author(s) 2019. This article is licensed under a Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/).
Keywords: Alzheimer's disease, Developmental disorders
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Department of Neuromuscular Diseases
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > UK Dementia Research Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Pharmacology
URI: https://discovery.ucl.ac.uk/id/eprint/10074478
Downloads since deposit
63Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item